Medical Advisory Board member and stem cell research pioneer Curt I. Civin, M.D. of the University of Maryland discusses scientist's new-found ability to harness a patient's immune system to combat cancer. He also cites advances in this field that have been made and supported by Gabrielle's Angel Foundation grantees.
Dr. Civin's breakthrough discovery of the CD34 lympho-hematopoietic stem cell antigen and monoclonal antibody has facilitated basic research in stem cell biology and leukemia and has led to improved stem cell transplantation for thousands of patients. To learn more about Dr. Civin's work, please visit: medschool.umaryland.edu/facultyresearchprofile/viewprofile.aspx?id=21250